U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07033715) titled 'Exercise in Hereditary ATTR (ATTRv) Amyloidosis' on April 18.
Brief Summary: This study aims to explore the effects of a 12-week exercise intervention on the physical and mental health of people living with Hereditary ATTR (ATTRv) Amyloidosis, a rare genetic disease caused by mutations in the transthyretin gene, leading to the deposition of amyloid fibrils in nerves and organs.
Study Start Date: Oct. 01, 2024
Study Type: INTERVENTIONAL
Condition:
Amyloidosis, Hereditary, Transthyretin-Related
Intervention:
OTHER: Exercise
The exercise sessions will have a frequency of 3 times a week and a duration of 60 minutes per session. E...